Precigen (PGEN) Receivables - Other (2012 - 2026)
Precigen's (PGEN) quarterly Receivables - Other came in at $302000.0 in Q1 2026, down 3.51% year-on-year from $313000.0 in Q1 2025, and up 508.11% on a QoQ basis from -$74000.0 in Q4 2025.
Precigen (PGEN) Receivables - Other (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Receivables - Other data on file, last reported at $302000.0 in Q1 2026.
- On a quarterly basis, Receivables - Other fell 3.51% year-over-year to $302000.0 in Q1 2026; TTM through Mar 2026 was $302000.0, a 3.51% decrease from a year earlier, with the FY2025 full-year figure at $446000.0, up 201.83% from the prior year.
- Receivables - Other for Q1 2026 stood at $302000.0, up from -$74000.0 in the prior quarter.
- Over the last five years, Receivables - Other for PGEN reached as high as $13.8 million in Q1 2023 and fell as low as -$12.4 million in Q4 2023.
- Historically, Receivables - Other has averaged $2.5 million across 5 years, with a median of $302000.0 in 2026.
- Across the five-year window, Receivables - Other surged 72411.11% in 2023 and tumbled 957.14% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $11.6 million in 2022, then slumped by 206.87% to -$12.4 million in 2023, then soared by 99.94% to -$7000.0 in 2024, then tumbled by 957.14% to -$74000.0 in 2025, then surged by 508.11% to $302000.0 in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $302000.0 in Q1 2026, -$74000.0 in Q4 2025, and $520000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302,000.00 |
| Mar 31, 2026 | 302,000.00 |
| Dec 31, 2025 | -74,000.00 |
| Dec 31, 2025 | -74,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 505,000.00 |
| Mar 31, 2024 | -383,000.00 |
| Mar 31, 2024 | -383,000.00 |
| Dec 31, 2023 | -12.42 Mn |
| Dec 31, 2023 | -12.42 Mn |